Greif: A Stronger Balance Sheet, But Limited Upside Ahead (Downgrade)

Greif, Inc. was downgraded to Hold on valuation concerns and mixed financial performance, despite asset sales that reduced net debt from $2.56 billion to $769.3 million and improved leverage. Revenue was $3.23 billion in the first nine months of fiscal 2026, with growth described as minimal; profitability was inflated by one-off gains.

Analysis

The key question is whether the post-divestiture Greif can earn an adequate return on a smaller, more focused asset base—not whether the balance sheet looks cleaner. Lower debt improves financial flexibility, but it does not by itself establish stronger recurring cash generation; asset sales can also reduce earnings diversity and leave reported profitability harder to underwrite when gains obscure the run rate. For equity, the burden shifts to organic price/mix, volume and cash conversion. For credit, reduced gross debt is a more direct positive, though leverage should be assessed against post-sale recurring EBITDA and liquidity needs rather than historical scale.

Near term, valuation may limit upside until results separate recurring operating performance from transaction-related gains. Over 1–3 months, watch guidance and cash conversion for evidence that the continuing businesses can sustain margins. Over 6–18 months, the structural test is whether capital allocation and operating execution compensate for the smaller portfolio. Containerboard capacity transferred to a buyer could remain in the market; any effect on packaging input costs depends on whether that capacity stays productive, so this is a monitor rather than a directional supply assumption.

Contrarian angle: deleveraging may make the credit risk/reward more attractive even if the equity does not yet warrant a higher multiple. The thesis weakens if recurring cash flow deteriorates, guidance is cut, or debt reduction fails to translate into lower financing risk.

Key Decisions for Investors

• No high-conviction directional equity trade on the available information. Avoid chasing the deleveraging narrative until reported results provide a clean view of recurring earnings and post-sale cash generation.
• For existing GEF exposure, frame the position around execution rather than balance-sheet repair: reassess if organic volume/price trends or operating cash conversion disappoint in the next reporting cycle.
• Treat GEF credit as a watch-list candidate, not an automatic buy. Verify current bond yields, maturities, liquidity and post-divestiture recurring EBITDA before judging whether lower debt is already reflected in spreads.
• Falsification/watch items: a guidance reduction, weakening recurring cash conversion, or leverage that fails to improve on a post-sale EBITDA basis would undermine the recovery case; sustained operating performance without one-off support would improve it.